Prices are updated after-hours

Manufacturing 2021 - 09 - 09

Capstone Green Energy Corp.

CGRN | $0.37 -18.49% 1.8M

(0.0% 1d) (0.0% 1m) (-69.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (18.86% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 6,788,701
https://www.CapstoneGreenEnergy.com
Sec Filling | Patents | n/a employees

Capstone Green Energy is a leading provider of customized microgrid solutions and on-site energy technology systems focused on helping customers around the globe meet their environmental, energy savings, and resiliency goals. Capstone Green Energy focuses on four key business lines. Through its Energy as a Service (EaaS) business, it offers rental solutions utilizing its microturbine energy systems and battery storage systems, comprehensive Factory Protection Plan (FPP) service contracts that guarantee life-cycle costs, as well as aftermarket parts. Energy Conversion Products are driven by the Company's industry-leading, highly efficient, low-emission, resilient microturbine energy systems offering scalable solutions in addition to a broad range of customer-tailored solutions, including hybrid energy systems and larger frame industrial turbines. The Energy Storage Products business line designs and installs microgrid storage systems creating customized solutions using a combination of battery technologies and monitoring software. Through Hydrogen Energy Solutions, Capstone Green Energy offers customers a variety of hydrogen products, including the Company's microturbine energy systems.

energy msa battery batteries ycombinator

add to watch list Paper trade email alert is off

MamaMancini`s Holdings Inc

MMMB 4 | $3.75 1.08% 1.07% 190K

Manufacturing

(0.0% 1d) (0.0% 1m) (102.7% 1y) (0.0% 2d) (0.0% 3d) (5.3% 7d) (Infinity% volume)
Earnings Calendar: 2023-09-14
Market Cap: $ 136,817,914
https://www.mamamancinis.com
Sec Filling | Patents | 9 employees

MamaMancini's Holdings, Inc. is a marketer and distributor of specialty prepared, refrigerated and frozen all-natural Italian foods. MamaMancini’s product portfolio consists of over 20 products including meatballs, meat loaf, chicken parmesan, sausages and pasta bowl kits, with beef, turkey, chicken and pork varieties. The Company’s products are sold in over 45,000 locations nationwide, including at well-known retailers such as Sam’s Club, Whole Foods, Publix, Costco and Albertsons, as well as through national distributors such as Sysco and United Natural Foods. The Company also regularly maintains a direct-to-consumer presence through presentations on QVC.

add to watch list Paper trade email alert is off

Burcon Nutrascience Corp

BRCN | $0.44 0.0%

Manufacturing

(0.0% 1d) (0.0% 1m) (0.0% 1y) (-4.8% 2d) (-3.8% 3d) (0.0% 7d) (-31.58% volume)
Earnings Calendar:
Market Cap:
https://www.burcon.ca/
Sec Filling | Patents | 16 employees

(CA) Burcon is a global technology leader in the development of clean-label, plant-based proteins for foods and beverages. With over 290 issued patents and 200 additional patent applications developed over a span of more than 20 years, Burcon has grown an extensive portfolio of composition, application and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation ("Merit Foods") was established between Burcon and three veteran food industry executives. Merit Foods has built a state-of-the-art protein production facility in Manitoba, Canada to produce, under licence, Burcon’s novel pea and canola protein ingredients.

add to watch list Paper trade email alert is off

IM Cannabis Corp

IMCC | $0.611 -15.93% -18.95% 600K

Manufacturing

(0.0% 1d) (203.3% 1m) (38.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-62.84% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 8,181,016
https://imcannabis.com
Sec Filling | Patents | 2020 employees

IMC is an MCO in the medical cannabis sector headquartered in Israel and with operations In Israel and Germany. Over the past decade, the Company believes that the IMC brand has become synonymous with quality and consistency in the Israeli medical cannabis market. The Company has also expanded its business to offer intellectual property-related services to the medical cannabis industry. In Europe, IMC operates through Adjupharm GmbH ("Adjupharm"), a German-based subsidiary and EU-GMP certified medical cannabis distributor. IMC's European presence is augmented by strategic alliances with various pan-European EU-GMP cultivators and distributors to capitalize on the increased demand for medical cannabis products in Europe and bring the IMC brand and its product portfolio to European patients.

israel brands cannabis

add to watch list Paper trade email alert is off

Cricut Inc - Class A

CRCT | $5.18 3.81% 3.76% 710K

Manufacturing

(0.0% 1d) (-2.3% 1m) (-49.1% 1y) (0.0% 2d) (0.0% 3d) (-0.2% 7d) (-19.84% volume)
Earnings Calendar: 2024-03-05
Market Cap: $ 262,048,513
https://cricut.com
Sec Filling | Patents | n/a employees

Cricut Inc. is a creative technology platform company dedicated to encouraging new ways for people to experience making at home. As an empowering lifestyle brand, Cricut’s mission is to unleash the creative potential of its users with innovations that bring ideas to life in the form of professional-looking, personalized handmade projects. Cricut’s industry-leading products include its flagship line of smart cutting machines—Cricut Maker®, the Cricut Explore® family, and Cricut Joy®— accompanied by other unique tools like Cricut EasyPress®, the Infusible Ink™ system, and a diverse collection of materials. In addition to Cricut’s core offerings, the brand also fosters a thriving community of more than four million dedicated users worldwide.

brands

add to watch list Paper trade email alert is off

NeuroPace Inc

NPCE S | $14.0 1.82% 2.27% 65K

Manufacturing

(0.0% 1d) (0.8% 1m) (197.6% 1y) (0.0% 2d) (0.0% 3d) (2.6% 7d) (-70.22% volume)
Earnings Calendar: 2024-03-05
Market Cap: $ 367,971,436
https://www.neuropace.com
Sec Filling | Patents | 167 employees

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy, and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

education treatment

add to watch list Paper trade email alert is off

Wrap Technologies Inc

WRAP | $2.08 8.9% 8.17% 680K

Manufacturing

(0.0% 1d) (-25.2% 1m) (64.7% 1y) (0.0% 2d) (0.0% 3d) (-0.5% 7d) (16.03% volume)
Earnings Calendar: 2024-04-30
Market Cap: $ 91,965,472
https://wrap.com
Sec Filling | Patents | 52 employees

Wrap Technologies is an innovator of modern policing solutions. The Company's BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a distance from 10 to 25 feet. Developed by award winning inventor Elwood Norris, the Company's Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement in safely and effectively deescalating encounters, especially those involving an individual in crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge.

add to watch list Paper trade email alert is off

Nuwellis Inc

NUWE | $0.2604 -6.26% -6.03% 520K

Manufacturing

(0.0% 1d) (-37.8% 1m) (-93.6% 1y) (0.0% 2d) (0.0% 3d) (-24.0% 7d) (431.14% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 1,771,096
https://www.nuwellis.com
Sec Filling | Patents | 15027 employees

(US) Nuwellis, Inc. , formally CHF Solutions, is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, Minn., with a wholly-owned subsidiary in Ireland. The Company has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions

brands

add to watch list Paper trade email alert is off

Byrna Technologies Inc

BYRN | $12.75 -0.39% -0.47% 240K

Manufacturing

(0.0% 1d) (-6.9% 1m) (125.9% 1y) (0.0% 2d) (0.0% 3d) (-8.2% 7d) (-15.21% volume)
Earnings Calendar: 2024-02-14
Market Cap: $ 289,890,337
https://byrna.com
Sec Filling | Patents | 175 employees

Byrna is a technology company, specializing in the development, manufacture, and sale of innovative non-lethal personal security solutions. The Company is the manufacturer of the Byrna® HD personal security device, a state-of-the-art handheld CO2 powered launcher designed to provide a non-lethal alternative to a firearm for the consumer, private security, and law enforcement markets.

security

add to watch list Paper trade email alert is off

Latham Group Inc

SWIM | $3.06 -3.77% -3.92% 170K

Manufacturing

(0.0% 1d) (-7.6% 1m) (38.3% 1y) (0.0% 2d) (0.0% 3d) (-5.6% 7d) (-15.78% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 353,082,604
https://www.lathampool.com
Sec Filling | Patents | 2198 employees

Latham, the Pool Company™, headquartered in Latham, NY, is the largest designer, manufacturer and marketer of in-ground residential swimming pools in North America, Australia and New Zealand. With a coast-to-coast operations platform consisting of over 2,000 employees across 32 facilities, Latham has sold over 8,700 fiberglass pools in the United States in 2020.

add to watch list Paper trade email alert is off

Eledon Pharmaceuticals Inc

ELDN | $1.99 26.75% 21.11% 300K

Manufacturing

(0.0% 1d) (-5.3% 1m) (-35.5% 1y) (0.0% 2d) (0.0% 3d) (-2.4% 7d) (-75.9% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 49,378,129
http://novustherapeutics.com/
Sec Filling | Patents | 10 employees

(US) Novus Therapeutics, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company’s lead compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential. The CD40L/CD40 pathway is widely recognized for its prominent role in immune regulation. CD40L is primarily expressed on activated CD4+ T cells, platelets and endothelial cells while the CD40 receptor is constitutively expressed on antigen presenting cells such as B cells, macrophages, and dendritic cells. By blocking CD40L and not the CD40 receptor, AT-1501 inhibits both the CD40 and CD11 costimulatory signaling pathways, providing the potential for improved efficacy compared to anti-CD40 receptor approaches. Blocking CD40L also increases polarization of CD4+ lymphocytes to Tregs, a specialized subpopulation of T cells that act to suppress an immune response, thus creating a more tolerogenic environment, which is especially important for autoimmune diseases and in the transplant setting. Furthermore AT-1501 is an IgG1 antibody specifically engineered to cripple the Fc effector function to potentially improve safety, as well as potentially provide pharmacokinetic, pharmacodynamic, and dosing advantages compared to other approaches.

als ceiling treatment antibody t-cell

add to watch list Paper trade email alert is off

Nuvve Holding Corp

NVVE | $0.6606 0.05% 0.56% 91K

Manufacturing

(0.0% 1d) (-19.0% 1m) (6.2% 1y) (0.0% 2d) (0.0% 3d) (-1.7% 7d) (-48.1% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 4,009,785
https://nuvve.com
Sec Filling | Patents | 21 employees

Nuvve is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. Its mission is to lower the cost of electric vehicle ownership while supporting the integration of renewable energy sources, including solar and wind. Nuvve’s Grid Integrated Vehicle, GIVe™, platform is refueling the next generation of electric vehicle fleets through intelligent, bidirectional charging solutions. Since its founding in 2010, Nuvve has launched successful V2G projects on five continents and is deploying commercial services worldwide by developing partnerships with utilities, automakers, and electric vehicle fleets

energy electric vehicles solar vehicles renewable eletrical

add to watch list Paper trade email alert is off

Amplitech Group Inc

AMPG | $2.22 -2.2% 1.73% 7.6K

Manufacturing

(0.0% 1d) (22.6% 1m) (-28.1% 1y) (0.0% 2d) (0.0% 3d) (-3.4% 7d) (-72.53% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 21,571,991
https://www.amplitechinc.com
Sec Filling | Patents | 16 employees

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF components for the Domestic and International, SATCOM, Space, Defense and Military markets. These designs cover the frequency range from 50 kHz to 40 GHz - eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. Its steady growth over the past 13+ years has come about because AmpliTech can provide complex, custom solutions for nearly ANY custom requirements that are presented. In addition, AmpliTech has the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers' own designs.

military defense

add to watch list Paper trade email alert is off

CareMax Inc - Class A

CMAX | $2.4 -4.38% -11.8% 51K

Manufacturing

(0.0% 1d) (-46.4% 1m) (23.1% 1y) (0.0% 2d) (0.0% 3d) (-9.8% 7d) (-61.51% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 9,126,919
https://www.caremax.com
Sec Filling | Patents | 962 employees

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

add to watch list Paper trade email alert is off